Reply to: Biological Therapy in Patients with Rheumatoid Arthritis in a Tertiary Center in Portugal: A Cross-Sectional Study

Reply to: Biological Therapy in Patients with Rheumatoid Arthritis in a Tertiary Center in Portugal: A Cross-Sectional Study

N/a.

Bibliographic Details
Main Authors:	Joana Ramos Rodrigues, Daniela Santos-Faria, Carmo Afonso, José Tavares-Costa
Format:	Article
Language:	English
Published:	Ordem dos Médicos 2021-06-01
Series:	Acta Médica Portuguesa
Subjects:	Arthritis Rheumatoid/drug therapy Biological Products/therapeutic use Biological Therapy
Online Access:	https://actamedicaportuguesa.com/revista/index.php/amp/article/view/16513

Similar Items

Biological Therapy in Patients with Rheumatoid Arthritis in a Tertiary Center in Portugal: A Cross-Sectional Study
by: Melissa Fernandes, et al.
Published: (2021-05-01)

Biologic therapy of rheumatoid arthritis
by: Damjanov Nemanja, et al.
Published: (2009-01-01)

Dual Biologic Therapy in Patients with Rheumatoid Arthritis and Psoriatic Arthritis
by: Victoria Furer, et al.
Published: (2023-04-01)

THE PLACE OF TOFACITINIB IN THE TREATMENT STRATEGY OF RHEUMATOID ARTHRITIS
by: V. I. Mazurov, et al.
Published: (2018-05-01)

Pre-treatment antinuclear antibody positivity, therapeutic efficacy and persistence of biologics in rheumatoid arthritis
by: Codreanu Cătălin, et al.
Published: (2016-06-01)

Clinical predictors of multiple failure to biological therapy in patients with rheumatoid arthritis
by: Marta Novella-Navarro, et al.
Published: (2020-12-01)

Studying Cytokine Profile in Patients with Juvenile Rheumatoid Arthritis During Biological Therapy
by: Ya.Ye. Boyko, et al.
Published: (2014-08-01)

Factors associated with initial or subsequent choice of biologic disease-modifying antirheumatic drugs for treatment of rheumatoid arthritis
by: Yinzhu Jin, et al.
Published: (2017-07-01)

Rheumatoid arthritis: current therapeutics compendium
by: Dariushnejad Hassan, et al.
Published: (2022-04-01)

Association Between the Extent of Periodontal Inflammation and the Severity of Rheumatoid Arthritis in Japanese Patients With Rheumatoid Arthritis
by: Hiroko Hashimoto, et al.
Published: (2021-10-01)

Openness to and preference for attributes of biologic therapy prior to initiation among patients with rheumatoid arthritis: patient and rheumatologist perspectives and implications for decision making
by: Bolge SC, et al.
Published: (2016-06-01)

THE EFFECT OF ABATACEPT ON BLOOD BIOMARKERS IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: M. A. Borisova, et al.
Published: (2017-09-01)

Use of biological therapy in patients with rheumatoid arthritis in the Republic of Kazakhstan
by: M G Nogaeva, et al.
Published: (2015-08-01)

Cerebral Toxoplasmosis as an Uncommon Complication of Biologic Therapy for Rheumatoid Arthritis: Case Report and Review of the Literature
by: Gonçalo Borges de Almeida, et al.
Published: (2022-08-01)

Effect of biological treatment on the daily functioning of patients with rheumatoid arthritis
by: Miriam Miedziak, et al.
Published: (2017-08-01)

Effect of biological treatment on the daily functioning of patients with rheumatoid arthritis
by: Miriam Miedziak, et al.
Published: (2017-08-01)

The prevalence of rheumatoid arthritis in Western Australia
by: Khalid Almutairi, et al.
Published: (2022-12-01)

Right drug, right patient, right time: aspiration or future promise for biologics in rheumatoid arthritis?
by: Vasco C. Romão, et al.
Published: (2017-10-01)

Relationship between Tooth Loss and the Medications Used for the Treatment of Rheumatoid Arthritis in Japanese Patients with Rheumatoid Arthritis: A Cross-Sectional Study
by: Hiroko Hashimoto, et al.
Published: (2021-02-01)

Unveiling difficult-to-treat rheumatoid arthritis: long-term impact of biologic or targeted synthetic DMARDs from the KOBIO registry
by: Ju-Yang Jung, et al.
Published: (2023-09-01)

Simplified disease activity changes in real-world practice: a nationwide observational study of seropositive rheumatoid arthritis patients with moderate-to-high disease activity
by: Kichul Shin, et al.
Published: (2020-01-01)

Comorbidities of rheumatoid arthritis: A cross-sectional retrospective study
by: Ecaterina Ganceanu, et al.
Published: (2022-09-01)

Clinical course of patients with rheumatoid arthritis who continue or discontinue biologic therapy after hospitalization for infection: a retrospective observational study
by: Yusuke Kashiwado, et al.
Published: (2022-06-01)

Case Report: Severe thrombocytopenia induced by adalimumab in rheumatoid arthritis: A case report and literature review
by: Tiantian Liao, et al.
Published: (2022-10-01)

Patterns and factors associated with pneumococcal vaccination in a prospective cohort of 1,697 patients with rheumatoid arthritis
by: Konstantinos Thomas, et al.
Published: (2023-01-01)

Two-year clinical outcomes after discontinuation of long-term golimumab therapy in Korean patients with rheumatoid arthritis
by: Kichul Shin, et al.
Published: (2022-09-01)

Initial Treatment with Biological Therapy in Rheumatoid Arthritis
by: Jesús Tornero Molina, et al.
Published: (2023-12-01)

Do biologic therapies reduce aortic inflammation in rheumatoid arthritis patients?
by: D. A. M. Thuy Trang, et al.
Published: (2021-08-01)

Research progress on rheumatoid arthritis-associated depression
by: Nian Liu, et al.
Published: (2023-01-01)

MODERN VIEWS ON PATHOGENETIC THERAPY OF RHEUMATOID ARTHRITIS
by: D. G. Rekalov, et al.
Published: (2013-12-01)

Association between Carotid Intima-Media Thickness and the Use of Biological or Small Molecule Therapies in Patients with Rheumatoid Arthritis
by: Marta Rojas-Giménez, et al.
Published: (2021-12-01)

Egyptian guidelines for the treatment of Rheumatoid Arthritis — 2022 update
by: Yasser El Miedany, et al.
Published: (2022-10-01)

Serum TNFα levels at 24 h after certolizumab pegol predict effectiveness at week 12 in patients with rheumatoid arthritis from TSUBAME study
by: Yusuke Miyazaki, et al.
Published: (2021-06-01)

Analysis of hematological parameters in rheumatoid arthritis patients receiving biological therapy
by: Jana Pereckova, et al.
Published: (2022-03-01)

Does periodontitis affect the treatment response of biologics in the treatment of rheumatoid arthritis?
by: Masahiro Tachibana, et al.
Published: (2020-07-01)

An Evidence-Based Update on the Potential Association between Rheumatoid Arthritis and Lymphangioleiomyomatosis
by: Nicoleta Anamaria Pascalau, et al.
Published: (2023-03-01)

Clinicopatological variants and risk factors for chronic kidney disease in rheumatoid arthritis
by: N. V. Chebotareva, et al.
Published: (2020-06-01)

Ultrasound of the hand is sufficient to detect subclinical inflammation in rheumatoid arthritis remission: a post hoc longitudinal study
by: Hilde Berner Hammer, et al.
Published: (2017-10-01)

Patient-reported fatigue in patients with rheumatoid arthritis who commence biologic therapy: a longitudinal study
by: Hege Selheim Rinke, et al.
Published: (2019-04-01)

Risk of hepatitis B reactivation in HBsAg−/HBcAb+ patients after biologic or JAK inhibitor therapy for rheumatoid arthritis: A meta‐analysis
by: Xuezhi Hong, et al.
Published: (2023-02-01)